Sanofi is one of many companies developing a vaccine. Image: PA Sanofi is one of many companies developing a vaccine. Image: PA FRENCH PHARMA GIANT Sanofi has said that international Phase 3 clinical tests of its Kevzara drug for serious Covid-19 cases had proved inconclusive and it was halting the trial.
Sanofi said neither it nor its American partner in developing the drug, Regeneron, “envisage further clinical tests of Kevzara for the treatment of Covid-19.” Since the outbreak of the coronavirus pandemic late last year in China, it has claimed more than 800,000 lives and caused huge economic damage, sparking a global race to find a vaccine and effective treatments.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite: